A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia
- PMID: 14985266
- DOI: 10.1093/brain/awh125
A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia
Erratum in
- Brain. 2004 Sep;127(Pt 9):2148
Abstract
Mutations in the SPG7 gene, encoding the mitochondrial protein paraplegin, were the first to be identified in autosomal recessive hereditary spastic paraplegia (ARHSP). Four different SPG7 mutations have been described so far in association with both pure and complicated HSP phenotypes. Muscle biopsies from the most severely affected patients have shown histological evidence of an oxidative phosphorylation defect. We identified six ARHSP kindreds, in whom linkage to SPG7 could not be excluded, and 29 sporadic spastic paraplegia patients. The 17 exons and flanking regions of the SPG7 gene were screened for mutations using a combination of single-stranded conformation polymorphism (SSCP) analysis and sequencing. Three patients were found to carry compound heterozygous SPG7 mutations, comprising five novel and one previously described mutation. Muscle biopsies from two SPG7 mutation patients did not show any histological evidence of an oxidative phosphorylation defect. However, biochemical analysis revealed a reduction in citrate synthase-corrected complex I and complex II/III activities in muscle and complex I activity in mitochondrial-enriched fractions from cultured myoblasts, suggesting that either a primary or a secondary defect of respiratory chain function may play an important role in the pathogenesis of the disease.
Similar articles
-
Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia.Neurology. 2006 Mar 14;66(5):654-9. doi: 10.1212/01.wnl.0000201185.91110.15. Neurology. 2006. PMID: 16534102
-
A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia.Hum Mutat. 2008 Apr;29(4):522-31. doi: 10.1002/humu.20682. Hum Mutat. 2008. PMID: 18200586
-
A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects.Mov Disord. 2010 Mar 15;25(4):413-20. doi: 10.1002/mds.22949. Mov Disord. 2010. PMID: 20108356
-
[AAA ATPases and hereditary spastic paraplegia].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):298-301. doi: 10.3760/cma.j.issn.1003-9406.2009.03.013. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19504443 Review. Chinese.
-
Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia.Trends Mol Med. 2006 Jun;12(6):262-9. doi: 10.1016/j.molmed.2006.04.002. Epub 2006 May 2. Trends Mol Med. 2006. PMID: 16647881 Review.
Cited by
-
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.Brain. 2012 Oct;135(Pt 10):2980-93. doi: 10.1093/brain/aws240. Brain. 2012. PMID: 23065789 Free PMC article.
-
The in-depth evaluation of suspected mitochondrial disease.Mol Genet Metab. 2008 May;94(1):16-37. doi: 10.1016/j.ymgme.2007.11.018. Epub 2008 Feb 1. Mol Genet Metab. 2008. PMID: 18243024 Free PMC article. Review.
-
Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.J Neurol. 2015 Jul;262(7):1601-12. doi: 10.1007/s00415-014-7598-y. Epub 2014 Dec 6. J Neurol. 2015. PMID: 25480570 Free PMC article.
-
SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia.J Hum Genet. 2019 Nov;64(11):1145-1151. doi: 10.1038/s10038-019-0669-2. Epub 2019 Sep 12. J Hum Genet. 2019. PMID: 31515523
-
Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegia.J Neurol. 2012 Feb;259(2):246-50. doi: 10.1007/s00415-011-6155-1. Epub 2011 Jul 2. J Neurol. 2012. PMID: 21725714
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical